Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to ...
Bayer announced today that data from across the KERENDIA (R) (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) ...
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) Kidney ...
The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.
The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for AstraZeneca India Pharma Limited's proposal ...
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from ...
New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to improvements in ...
It is administered intravenously to patients who are unable to take oral potassium supplements or when a rapid replacement of ...
Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
Multiple studies have shown that Covid infection increases the risk of cardiovascular diseases, including heart attack and ...
Money Talks News on MSN
Your heart, kidneys, and metabolism are connected—here's why it matters
Your heart health depends on more than just your heart. Discover why the American Heart Association is warning about CKM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback